Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.
Huguet F, Guerci-Bresler A, Roth-Guepin G, Cayssials E, Slama B, Santagostino A, Penot A, Quittet P, Cony-Makhoul P, Saad A, Bastie JN, Hacini M, Coiteux V, Uzunov M, Roy L, Le Clech L, Berger M, Agneray AM, Messas E, Etienne G, Turhan A, Nicolini FE, Rousselot P.
Huguet F, et al. Among authors: berger m.
Br J Haematol. 2024 Nov 6. doi: 10.1111/bjh.19819. Online ahead of print.
Br J Haematol. 2024.
PMID: 39506529